Fredun Pharmaceuticals has received large orders from Southeast Asian (SEA) countries, amounting to Rs 28 crore. These orders not only demonstrate the company's growing presence in the international markets but also hold substantial potential to scale up over the years, signifying a promising avenue for future growth and market penetration.
As part of its commitment to pioneering advancements in pet and veterinary care, the company has also initiated the development of three new molecules. These ground-breaking formulations, the first of their kind in India, are poised to revolutionize the landscape of veterinary medicine, addressing critical needs and enhancing the well-being of companion animals. This strategic endeavour underscores the company’s dedication to innovation and meeting evolving market demands in the veterinary sector.
Fredun Pharmaceuticals is engaged in manufacturing of pharmaceutical products.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |